Brief: Orphazyme Says Anders Fink Vadsholt Will Step Down As CEO/CFO Of Company

Strategic Partners A/S

30/05/2023 18:45

May 30 (Reuters) - Orphazyme A/S  ORPHA.CO :
    * MR. VADSHOLT WILL REMAIN AVAILABLE FOR COMPANY UNTIL HIS
REPLACEMENT HAS BEEN FOUND
    * ORPHAZYME > -  ANDERS FINK VADSHOLT HAS TODAY ENTERED INTO
A
SEVERANCE AGREEMENT PURSUANT TO WHICH MR. VADSHOLT WILL STEP
DOWN AS CEO/CFO OF COMPANY
    * ORPHAZYME - ALL DISPUTES RELATED TO US SECURITY CLASS
ACTION
CASE HAS BEEN FINALLY SETTLED, HOWEVER, IN NO EVENT LONGER THAN
UNTIL 1 OCTOBER 2023
    * FOR FULL-YEAR 2023 COMPANY ANTICIPATES AN OPERATING LOSS
IN
RANGE OF DKK 30 - 35 MILLION
    * COMPANY EXPECTS TO END 2023 WITH DKK 6 - 10 MILLION IN
CASH AND
IS THEREFORE REGARDED AS A GOING CONCERN

Source text for Eikon:  ID:nGNE1RpQgn 
Further company coverage:  ORPHA.CO 

 ((Reuters.Briefs@thomsonreuters.com;))